MarketPeel
Insider Trading Intelligence
TN

Ted C. Nark

AMRX
DIRECTOR · AMNEAL PHARMACEUTICALS, INC. · CIK 0001316851
FILING MIX · LIFETIME64%/36%
BUYS
14
SELLS
8
TOTAL VALUE
$586.0K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
325,848
AVG SELL PX
$11.72
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Ted C. Nark, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+4.92%+0.46%+4.46%+4.46%
14d1+0.00%+6.30%+2.19%+4.11%+4.11%
30d1+0.00%+6.48%+0.86%+5.62%+5.62%
60d1+0.00%+15.80%+3.90%+11.90%+11.90%
90d1+0.00%+27.98%+2.42%+25.56%+25.56%
180d1+0.00%+3.02%+11.51%-8.49%-8.49%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AMRX · 325,848 shares · as of May 7, 2026
085,257170,515255,772341,029202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 8 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
34,8190May 7, 2026May 8, 2026View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
34,819325,848May 7, 2026May 8, 2026View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,82419,824May 6, 2026May 8, 2026View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
50,000$11.72$586.0K291,029Nov 17, 2025Nov 19, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,81934,819May 6, 2025May 8, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
40,2580May 5, 2025May 8, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
40,258341,029May 5, 2025May 8, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
76,4530May 10, 2024May 14, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
76,453300,771May 10, 2024May 14, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,25840,258May 2, 2024May 6, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
80,128224,318May 10, 2023May 11, 2023View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
80,1280May 10, 2023May 11, 2023View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
76,45376,453May 9, 2023May 11, 2023View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
80,12880,128May 9, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
35,4060May 8, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
35,406144,190May 8, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
46,2180May 6, 2021May 7, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
46,218108,784May 6, 2021May 7, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,40635,406May 5, 2021May 7, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
6,45962,566May 7, 2020May 7, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
6,4590May 7, 2020May 7, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
46,21846,218May 5, 2020May 7, 2020View →
Other insiders · AMRX
Loading peer insiders…
About this filer
CIK 0001316851
ROLE
Director
PRIMARY
AMRX
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001316851DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback